Eidos Therapeutics
San Francisco, US · Founded 2013 · Delaware corporation · 2 known investors
Founders & leadership
Eidos Therapeutics was founded in 2013 by NEIL KUMAR.
NK
NEIL KUMARFounder
JF
JONATHAN FOXExecutive
US
UMA SINHAExecutive
CS
CHRISTINE SIUExecutive
HH
HOYOUNG HUHNamed on SEC filing
EA
ERIC AGUIARNamed on SEC filing
Board
RS
Investors · 2
Reported raises · per SEC filings
Form D private placements$26M disclosed across 1 round · 2018
▶$26MraisedApr 2018 · 13 investors · BiotechnologyRule 506(b)
▶$26MraisedApr 2018 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- RAJEEV SHAHDirector
- JONATHAN FOXExecutive Officer
- UMA SINHAExecutive Officer
- HOYOUNG HUHDirector
- NEIL KUMARExecutive Officer, Director
- ERIC AGUIARDirector
- CHRISTINE SIUExecutive Officer
- Offering amount
- $74M
- Amount sold
- $26M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Eidos Therapeutics?
- Eidos Therapeutics was founded by NEIL KUMAR in 2013.
- Who are Eidos Therapeutics's investors?
- Eidos Therapeutics's investors include Foresite Capital, RA Capital.
- How much funding has Eidos Therapeutics raised?
- Eidos Therapeutics has disclosed $26M raised across 1 round.
- Where is Eidos Therapeutics headquartered?
- Eidos Therapeutics is headquartered in San Francisco, US.